Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

United Therapeutics (UTHR) Return on Sales (2016 - 2025)

United Therapeutics' Return on Sales history spans 17 years, with the latest figure at 0.46% for Q4 2025.

  • For Q4 2025, Return on Sales rose 3860.0% year-over-year to 0.46%; the TTM value through Dec 2025 reached 0.42%, down 14.0%, while the annual FY2025 figure was 0.42%, 0.0% changed from the prior year.
  • Return on Sales for Q4 2025 was 0.46% at United Therapeutics, up from 0.42% in the prior quarter.
  • Across five years, Return on Sales topped out at 217.1% in Q4 2023 and bottomed at 38.14% in Q4 2024.
  • The 5-year median for Return on Sales is 0.41% (2024), against an average of 9.29%.
  • The largest annual shift saw Return on Sales soared 21683bps in 2023 before it plummeted -25524bps in 2024.
  • A 5-year view of Return on Sales shows it stood at 0.27% in 2021, then fell by -1bps to 0.27% in 2022, then soared by 80676bps to 217.1% in 2023, then plummeted by -118bps to 38.14% in 2024, then skyrocketed by 101bps to 0.46% in 2025.
  • Per Business Quant, the three most recent readings for UTHR's Return on Sales are 0.46% (Q4 2025), 0.42% (Q3 2025), and 0.39% (Q2 2025).